Target type: molecularfunction
Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: Na+(out) + H+(in) = Na+(in) + H+(out). [TC:2.A.35.1.1, TC:2.A.36.-.-]
Sodium:proton antiporter activity involves the movement of sodium ions (Na+) and protons (H+) across a membrane in opposite directions. This is a crucial process in maintaining cellular pH balance, ion homeostasis, and energy generation.
The antiporter protein facilitates this movement by binding to both sodium and proton ions simultaneously. The binding of one ion triggers a conformational change in the protein, allowing the other ion to be released on the opposite side of the membrane. This coupled transport is driven by the electrochemical gradient of sodium, which is typically higher outside the cell.
Specifically, the antiporter uses the energy released by the movement of sodium ions down their concentration gradient to pump protons against their concentration gradient. This proton gradient is then used to power other cellular processes, such as ATP synthesis (energy production) and nutrient uptake.
Sodium:proton antiporter activity is particularly important in the following contexts:
- **Regulation of intracellular pH:** By pumping protons out of the cell, the antiporter helps to maintain a stable intracellular pH, which is crucial for the proper functioning of enzymes and other cellular processes.
- **Nutrient absorption:** In the intestines, sodium:proton antiporters play a role in the absorption of nutrients like glucose and amino acids by creating a favorable concentration gradient for their uptake.
- **Cellular energy production:** In mitochondria, sodium:proton antiporters contribute to the generation of ATP by helping to maintain the proton gradient across the mitochondrial membrane.
Overall, sodium:proton antiporter activity is an essential mechanism for maintaining cellular homeostasis and energy production.'
"
Protein | Definition | Taxonomy |
---|---|---|
Na(+)/H(+) antiporter NhaA | A Na(+)/H(+) antiporter NhaA that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P13738] | Escherichia coli K-12 |
Multidrug transporter MdfA | A multidrug transporter MdfA that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0AEY8] | Escherichia coli K-12 |
Sodium/hydrogen exchanger 2 | A sodium/hydrogen exchanger 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UBY0] | Homo sapiens (human) |
Sodium/hydrogen exchanger 9B2 | A sodium/hydrogen exchanger 9B2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q86UD5] | Homo sapiens (human) |
Sodium/hydrogen exchanger 5 | A sodium/hydrogen exchanger 5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q14940] | Homo sapiens (human) |
Sodium/hydrogen exchanger 3 | A sodium/hydrogen exchanger 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P48764] | Homo sapiens (human) |
Sodium/hydrogen exchanger 1 | A sodium/hydrogen exchanger 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P19634] | Homo sapiens (human) |
Sodium/hydrogen exchanger 2 | A sodium/hydrogen exchanger 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UBY0] | Homo sapiens (human) |
Sodium/hydrogen exchanger 9B2 | A sodium/hydrogen exchanger 9B2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q86UD5] | Homo sapiens (human) |
Sodium/hydrogen exchanger 5 | A sodium/hydrogen exchanger 5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q14940] | Homo sapiens (human) |
Sodium/hydrogen exchanger 3 | A sodium/hydrogen exchanger 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P48764] | Homo sapiens (human) |
Sodium/hydrogen exchanger 1 | A sodium/hydrogen exchanger 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P19634] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
5-(n,n-hexamethylene)amiloride | 5-(N,N-hexamethylene)amiloride : A member of the class of pyrazines that is amiloride in which the two amino hydrogens at position N-5 are replaced by a hexamethylene moiety, resulting in the formation of an azepane ring. 5-(N,N-hexamethylene)amiloride: inhibitor of Na+-H+ exchange; has anti-HIV-1 activity | aromatic amine; azepanes; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines | antineoplastic agent; apoptosis inducer; odorant receptor antagonist; sodium channel blocker |
ethylisopropylamiloride | ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group. ethylisopropylamiloride: structure in first source | aromatic amine; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines; tertiary amino compound | anti-arrhythmia drug; neuroprotective agent; sodium channel blocker |
phloretin | dihydrochalcones | antineoplastic agent; plant metabolite | |
benzotriazole | benzotriazole : The simplest member of the class of benzotriazoles that consists of a benzene nucleus fused to a 1H-1,2,3-triazole ring. benzotriazole: inhibitor of atmospheric metal corrosion; also component of motion picture film & Neva brake fluid | benzotriazoles | environmental contaminant; xenobiotic |
amiloride | amiloride : A member of the class of pyrazines resulting from the formal monoacylation of guanidine with the carboxy group of 3,5-diamino-6-chloropyrazine-2-carboxylic acid. Amiloride: A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with DIURETICS to spare POTASSIUM loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705) | aromatic amine; guanidines; organochlorine compound; pyrazines | diuretic; sodium channel blocker |
amiloride hydrochloride | amiloride hydrochloride dihydrate : A hydrate that is the dihydrate of amiloride hydrochloride. | hydrate | diuretic; sodium channel blocker |
2-aminoperimidine | 2-aminoperimidine: inhibits bacterial NhaA Na/H+ antiporters; structure in first source | ||
cariporide | cariporide: a selective sodium-hydrogen exchange subtype 1 inhibitor; structure in first source | ||
eniporide | eniporide: inhibits NHE-1 isoform; structure in first source | ||
zoniporide | zoniporide: inhibits sodium-hydrogen exchanger isoform-1 (NHE-1) | ||
sabiporide | sabiporide: a NHE-1 inhibitor and a cardioprotective agent; structure in first source | ||
(5-(2-methoxy-5-chloro-5-phenyl)furan-2-ylcarbonyl)guanidine | (5-(2-methoxy-5-chloro-5-phenyl)furan-2-ylcarbonyl)guanidine: KR-32570 possesses potent cardioprotective effects in perfused rat hearts, and its effects may be mediated by inhibition of NHE-1, preservation of high-energy phosphates, and inhibition of lipid peroxidation | ||
tetracycline | tetracycline : A broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria. Tetracycline: A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis. | ||
minocycline | minocycline : A tetracycline analogue having a dimethylamino group at position 7 and lacking the methyl and hydroxy groups at position 5. Minocycline: A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections. | ||
methacycline | methacycline : A tetracycline that is the 6-methylene analogue of oxytetracycline, obtained by formal dehydration at position 6. Methacycline: A broad-spectrum semisynthetic antibiotic related to TETRACYCLINE but excreted more slowly and maintaining effective blood levels for a more extended period. | ||
tenapanor |